Q.LiL.et al (2022)
Zakrzewicz D, Zakrzewicz A, Didiasova M, Korencak M, Kosanovic D, Schermuly RT, et al
The Department of Health and Human Services referred questions to the White House, which did not respond to requests for comment on states termination of Medicaid coverage for the weight-loss drugs
*In OASIS 4 clinical trials of the oral Wegovy (semaglutide) pill, participants taking the medication with diet and exercise achieved average weight loss of about 14%17% over ~64 weeks compared with ~2% with placebo
It is not intended to diagnose, treat, cure or prevent any disease, and no therapeutic, metabolic-health, performance or anti-aging claims are made or implied
Lets dive in and use some 3D visuals from Visible Body to help illustrate how GLP-1s help with diabetes management and weight loss